PSIL ETF

$23.54

Fund Essentials - as of Apr 30, 2026

Net Assets
$44M
Expense Ratio
1.00%
Dividend Yield (Current)
7.19%
Holdings
31
Inception Date
Sep 15, 2021
Fund Family
Advisor Shares
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Quarterly

Performance

YTD+39.29%
1 Year+88.38%
3 Year+13.50%

Asset Allocation

Stocks: 99.17%
Other: 0.83%

Top Holdings

View All →
TickerNameWeight
-DREY INST PREF GOV MM-M12.85%
CMPSCompass Pathways Plc9.70%
ATAI:MUATAI:MU9.53%
DFTX:CADFTX:CA8.88%
RLMDRelmada Therapeutics Inc8.63%
Top 10 Concentration: 86.37%Report Date: Apr 30, 2026
Download all 31 holdings for PSIL
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
7.19%
Frequency
Quarterly

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

PSIL ETF Overview

PSIL ETF (ADVISORSHARES PSYCHEDELICS ETF) is managed by Advisor Shares with $44.4M in net assets. PSIL expense ratio is 1.00%, holding 31 positions across sectors including Unknown. Inception date: 2021-09-15.

PSIL performance shows a YTD return of 39.29%. The 1-year return is 88.38%. PSIL dividend yield stands at 7.19%, paid quarterly.

PSIL top holdings include DREY INST PREF GOV MM-M (12.8%), Compass Pathways Plc (9.7%), ATAI:MU (9.5%), DFTX:CA (8.9%), Relmada Therapeutics Inc (8.6%). View all PSIL holdings, sector breakdown, or dividend history.

PSIL can be compared against other funds using the overlap calculator or side-by-side comparison tool. PSIL alternatives are available via the screener, along with tax-loss harvesting opportunities.

1 Month
+9.77%
YTD
+39.29%
1 Year
+88.38%
3 Year
+13.50%

Top 10 Holdings (net long exposure of 171% (≈2x))

#TickerNameSectorWeight
1-DREY INST PREF GOV MM-MUnknown12.85%
2CMPSCompass Pathways PlcUnknown9.70%
3ATAI:MUATAI:MUUnknown9.53%
4DFTX:CADFTX:CAUnknown8.88%
5RLMDRelmada Therapeutics IncUnknown8.63%
6MNMDMind Medicine MindMed IncUnknown8.06%
7SAGESage Therapeutics IncUnknown7.66%
8ALKSAlkermes PLCUnknown7.60%
9-BLACKROCK TREASURY TRUSTUnknown7.07%
10ATAIATAI Life Sciences NVUnknown6.40%